Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston
Mariana Oncology at Discovery on Target 2026
Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website
Mariana Oncology brings 2 presentations to Discovery on Target 2026 in Boston. Its program centres on radioligand therapy for cancer, including a DLL3-targeting macrocyclic peptide for small cell lung cancer. It also weighs the science, strategy and scale needed to take a target to a therapy.
| Organization | Discovery on Target 2026 Attendance |
|---|---|
Radioligand therapy developer for cancer, acquired by Novartis in 2024. | Talk Tue Sep 29 8:35am–9:05am Panel Wed Sep 30 3:05pm–4:05pm |
Instantly find 20 buyers from Mariana Oncology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction